Cutsem, E. V., Eng, C., Nowara, E., Świeboda-Sadlej, A., Tebbutt, N. C., Mitchell, E., . . . Tabernero, J. (2014). Randomized Phase Ib/II Trial of Rilotumumab or Ganitumab with Panitumumab versus Panitumumab Alone in Patients with Wild-type KRAS Metastatic Colorectal Cancer. Clin Cancer Res.
Citación estilo ChicagoCutsem, Eric Van, et al. "Randomized Phase Ib/II Trial of Rilotumumab or Ganitumab With Panitumumab Versus Panitumumab Alone in Patients With Wild-type KRAS Metastatic Colorectal Cancer." Clin Cancer Res 2014.
Cita MLACutsem, Eric Van, et al. "Randomized Phase Ib/II Trial of Rilotumumab or Ganitumab With Panitumumab Versus Panitumumab Alone in Patients With Wild-type KRAS Metastatic Colorectal Cancer." Clin Cancer Res 2014.